The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

The American Heart Association and the American Red Cross today released the "2024 Guidelines for First Aid," which provide ...